Head of the Center for Regenerative Medicine at the University of Florida Medical School. Over 110 published manuscripts, 40 worldwide patents, more pending, invented the Closer (Perclose). His lab focuses on vascular biology w/emphasis on function and translational study of stem cells from adipose tissue. Recognized as a leading expert in adult stem cell research, advises the NIH on 2 committees, chairs one of them

Michael directed teams through discovery, process & clinical development, & regulatory affairs at GeneMedicine, Valentis, & Centelion, a subsidiary of Sanofi-Aventis. Most recently, he was President & CEO of InGeneron, where the company achieved regulatory approvals in Europe vi CE marks and initiated clinical trials in the US under FDA IDE.

Sales career with Bristol Myers Squibb. 10 yr. tenure included expertise in multiple therapeutic areas, several product launches, primary care/hospital experience & she enjoyed consistent recognition for success. In the not-for-profit sector, Karen successfully created, marketed, and led 2 local organizations & raised funds for 2 charitable causes via speech writing/presenting